Examination of Vertebroplasty in Addition to Regular Treatment of Patients With Multiple Myeloma.

Launched by SPINE CENTRE OF SOUTHERN DENMARK · Aug 26, 2020

Keywords

ClinConnect Summary

This clinical trial is studying the effectiveness of a procedure called vertebroplasty for patients with multiple myeloma who have recently developed painful fractures in their spine. Vertebroplasty involves injecting a special cement into the vertebrae to help stabilize them and reduce pain. The trial will compare two groups of patients: one group will receive their usual medical treatment for multiple myeloma and the spinal fractures, while the other group will get the same medical treatment plus the vertebroplasty procedure. The goal is to see if adding vertebroplasty helps improve pain and overall treatment outcomes for these patients.

To be eligible for this trial, participants should be between the ages of 65 and 74, have a confirmed diagnosis of multiple myeloma, and have up to four recent vertebral fractures causing significant pain. However, patients with certain conditions, like nerve problems or severe psychological issues, cannot participate. If you join the study, you will have regular check-ups and assessments to monitor your health and pain levels throughout the trial. This is an important opportunity to learn more about how vertebroplasty might help improve treatment for people with multiple myeloma and spinal fractures.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • known multiple myeloma
• • verified lesion(s) between Th6-L5
• • 4 or less fractures
• • relevant pain in 3 months or less
• • vertebroplasty can be performed in one procedure
• • VAS 5 or more
• Exclusion Criteria:
• • presence of neurologic deficit
• • psychological or psychiatric disorder hat is expected to interfere with compliance